Financhill
Sell
49

FUJHY Quote, Financials, Valuation and Earnings

Last price:
$8.25
Seasonality move :
3.1%
Day range:
$7.97 - $8.61
52-week range:
$7.51 - $11.76
Dividend yield:
4.16%
P/E ratio:
4.67x
P/S ratio:
0.39x
P/B ratio:
0.68x
Volume:
139.7K
Avg. volume:
267.4K
1-year change:
-9.04%
Market cap:
$12.1B
Revenue:
$32.6B
EPS (TTM):
$1.77
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue $30.8B $26.7B $24.4B $28B $32.6B
Revenue Growth (YoY) 8.08% -13.23% -8.43% 14.34% 16.6%
 
Cost of Revenues $25.1B $22.1B $20B $22.5B $25.7B
Gross Profit $5.7B $4.6B $4.5B $5.5B $6.9B
Gross Profit Margin 18.41% 17.41% 18.36% 19.51% 21.1%
 
R&D Expenses $850.7M $982.5M $922.7M $847.2M $786.6M
Selling, General & Admin $2.8B $2.6B $2.7B $2.5B $2.8B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $3.7B $3.7B $3.7B $3.5B $3.6B
Operating Income $1.9B $967.7M $817.4M $2B $3.3B
 
Net Interest Expenses $24.5M -- -- -- --
EBT. Incl. Unusual Items $1.9B $1.1B $952.9M $2.1B $3.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $506.6M $345.6M $324M $587.1M $1B
Net Income to Company $1.9B $1.1B $952.9M $2.1B $3.7B
 
Minority Interest in Earnings -$36.8K -$7.6M -$5.2M $10M $3.6M
Net Income to Common Excl Extra Items $1.4B $721.7M $623.6M $1.5B $2.7B
 
Basic EPS (Cont. Ops) $0.92 $0.47 $0.41 $0.97 $1.76
Diluted EPS (Cont. Ops) $0.92 $0.47 $0.41 $0.97 $1.76
Weighted Average Basic Share $1.5B $1.5B $1.5B $1.5B $1.5B
Weighted Average Diluted Share $1.5B $1.5B $1.5B $1.5B $1.5B
 
EBITDA $3.9B $3.1B $3B $4B $5.3B
EBIT $2.1B $1.2B $981.4M $2.3B $3.8B
 
Revenue (Reported) $30.8B $26.7B $24.4B $28B $32.6B
Operating Income (Reported) $1.9B $967.7M $817.4M $2B $3.3B
Operating Income (Adjusted) $2.1B $1.2B $981.4M $2.3B $3.8B
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $4.2B $5.8B $6.4B $7.9B $7B
Revenue Growth (YoY) -43.99% 36.64% 10.93% 22.51% -11.16%
 
Cost of Revenues $3.5B $4.6B $5.4B $6.4B $5.6B
Gross Profit $729.6M $1.2B $1.1B $1.5B $1.4B
Gross Profit Margin 17.18% 20.02% 16.8% 18.57% 19.94%
 
R&D Expenses $299.1M $229.5M $193.1M $201.5M $155.5M
Selling, General & Admin $561.7M $652.8M $605.1M $647.2M $647.5M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $874.3M $893.7M $792M $850.8M $812.3M
Operating Income -$144.7M $267.9M $289.3M $613.7M $584.4M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$99.8M $313M $296.4M $840.7M $693M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$29.6M $141M $85.9M $311.2M $154M
Net Income to Company -$99.8M $313M $296.4M $840.7M --
 
Minority Interest in Earnings -$1.4M -$2.8M -$540.2K $4.2M -$83.4K
Net Income to Common Excl Extra Items -$71.6M $169.1M $210M $533.8M $538.9M
 
Basic EPS (Cont. Ops) -$0.05 $0.11 $0.14 $0.35 $0.36
Diluted EPS (Cont. Ops) -$0.05 $0.11 $0.14 $0.35 $0.36
Weighted Average Basic Share $1.5B $1.5B $1.5B $1.5B $1.5B
Weighted Average Diluted Share $1.5B $1.5B $1.5B $1.5B $1.5B
 
EBITDA $376.6M $893.9M $833.3M $1.3B $1.2B
EBIT -$76.6M $368.1M $398.5M $916M $792.3M
 
Revenue (Reported) $4.2B $5.8B $6.4B $7.9B $7B
Operating Income (Reported) -$144.7M $267.9M $289.3M $613.7M $584.4M
Operating Income (Adjusted) -$76.6M $368.1M $398.5M $916M $792.3M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $27.4B $28.3B $25.1B $29.3B $31.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $22.7B $23.2B $20.6B $23.5B $24.9B
Gross Profit $4.7B $5.1B $4.4B $5.8B $6.8B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $983.6M $911.5M $887M $856.3M $740.5M
Selling, General & Admin $2.7B $2.7B $2.6B $2.6B $2.7B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $3.8B $3.7B $3.6B $3.5B $3.6B
Operating Income $947.2M $1.4B $842.9M $2.3B $3.2B
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $988M $1.5B $940.9M $2.6B $3.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $267.5M $519.2M $268.7M $807.7M $871.2M
Net Income to Company $997.9M $1.5B $936.3M $2.6B --
 
Minority Interest in Earnings -$278.8K -$9.1M -$3M $14.5M -$511.9K
Net Income to Common Excl Extra Items $720.2M $970.3M $669.2M $1.8B $2.7B
 
Basic EPS (Cont. Ops) $0.47 $0.63 $0.44 $1.17 $1.77
Diluted EPS (Cont. Ops) $0.47 $0.63 $0.44 $1.17 $1.77
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $3B $3.6B $3B $4.5B $5.4B
EBIT $1.2B $1.6B $1.1B $2.7B $4B
 
Revenue (Reported) $27.4B $28.3B $25.1B $29.3B $31.7B
Operating Income (Reported) $947.2M $1.4B $842.9M $2.3B $3.2B
Operating Income (Adjusted) $1.2B $1.6B $1.1B $2.7B $4B
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $4.2B $5.8B $6.4B $7.9B $7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $3.5B $4.6B $5.4B $6.4B $5.6B
Gross Profit $729.6M $1.2B $1.1B $1.5B $1.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $299.1M $229.5M $193.1M $201.5M $155.5M
Selling, General & Admin $561.7M $652.8M $605.1M $647.2M $647.5M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $874.3M $893.7M $792M $850.8M $812.3M
Operating Income -$144.7M $267.9M $289.3M $613.7M $584.4M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$99.8M $313M $296.4M $840.7M $693M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$29.6M $141M $85.9M $311.2M $154M
Net Income to Company -$99.8M $313M $296.4M $840.7M --
 
Minority Interest in Earnings -$1.4M -$2.8M -$540.2K $4.2M -$83.4K
Net Income to Common Excl Extra Items -$71.6M $169.1M $210M $533.8M $538.9M
 
Basic EPS (Cont. Ops) -$0.05 $0.11 $0.14 $0.35 $0.36
Diluted EPS (Cont. Ops) -$0.05 $0.11 $0.14 $0.35 $0.36
Weighted Average Basic Share $1.5B $1.5B $1.5B $1.5B $1.5B
Weighted Average Diluted Share $1.5B $1.5B $1.5B $1.5B $1.5B
 
EBITDA $376.6M $893.9M $833.3M $1.3B $1.2B
EBIT -$76.6M $368.1M $398.5M $916M $792.3M
 
Revenue (Reported) $4.2B $5.8B $6.4B $7.9B $7B
Operating Income (Reported) -$144.7M $267.9M $289.3M $613.7M $584.4M
Operating Income (Adjusted) -$76.6M $368.1M $398.5M $916M $792.3M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Cash and Equivalents $7.9B $8.2B $7.2B $7.4B $6.9B
Short Term Investments $1.9B $2.1B $2B $2.9B $5.8B
Accounts Receivable, Net $3.4B $3.1B $2.8B $2.7B $2.5B
Inventory $4.3B $3.8B $4B $4.5B $3.9B
Prepaid Expenses -- -- -- -- --
Other Current Assets $691.6M $601.7M $632M $745.8M $784.9M
Total Current Assets $18.3B $18B $16.7B $18.2B $19.9B
 
Property Plant And Equipment $7.6B $7.6B $6.9B $6.5B $6.4B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1B $1.2B $1.3B $1.4B $1.5B
Total Assets $30.5B $30.9B $29B $29.6B $31.8B
 
Accounts Payable $3.1B $2.4B $2.2B $2.8B $2.5B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $3B $2.9B $2.5B $2.6B $2.9B
Total Current Liabilities $9.1B $7.9B $7B $7.6B $8.1B
 
Long-Term Debt $2.1B $2.8B $2.3B $1.9B $2.2B
Capital Leases -- -- -- -- --
Total Liabilities $14.6B $14.7B $13.5B $13.8B $14.9B
 
Common Stock $1.4B $1.4B $1.3B $1.2B $1B
Other Common Equity Adj -- -- -- -- --
Common Equity $15.8B $16.1B $15.5B $15.8B $16.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $67M $78.4M $83.8M $67.3M $14.5M
Total Equity $15.9B $16.2B $15.6B $15.8B $16.9B
 
Total Liabilities and Equity $30.5B $30.9B $29B $29.6B $31.8B
Cash and Short Terms $9.8B $10.3B $9.2B $10.3B $12.7B
Total Debt $2.2B $3B $2.7B $2.3B $2.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $8.4B $7.6B $7.2B $6.1B $6.8B
Short Term Investments $2B $2B $1.9B $4.2B $6.1B
Accounts Receivable, Net $3.3B $2.9B $2.3B $2.5B $2.7B
Inventory $4.3B $3.5B $4.2B $4.4B $4.2B
Prepaid Expenses -- -- -- -- --
Other Current Assets $693M $631.3M $663.9M $959.8M $908.1M
Total Current Assets $18.8B $16.7B $16.4B $18.3B $20.8B
 
Property Plant And Equipment $7.7B $7.5B $5.9B $6.1B $7.2B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1.1B $1.2B $1.3B $1.4B $1.5B
Total Assets $31.1B $29.7B $27.2B $29.2B $33.6B
 
Accounts Payable $3B $1.6B $2.2B $3B $2.9B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $2.7B $2.7B $2.5B $2.5B $3.3B
Total Current Liabilities $8.4B $6.4B $6.9B $7.9B $8.9B
 
Long-Term Debt $3B $2.9B $1.9B $1.7B $2.3B
Capital Leases -- -- -- -- --
Total Liabilities $14.9B $13.4B $12.9B $13.8B $15.8B
 
Common Stock $1.5B $1.4B $1.1B $1B $1.1B
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $75.9M $83.2M $72.7M $14.3M $15.6M
Total Equity $16.2B $16.3B $14.3B $15.4B $17.8B
 
Total Liabilities and Equity $31.1B $29.7B $27.2B $29.2B $33.6B
Cash and Short Terms $10.4B $9.5B $9.1B $10.2B $12.9B
Total Debt $3.2B $3B $2.3B $2.2B --
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders $1.9B $1.1B $952.9M $2.1B $3.7B
Depreciation & Amoritzation $1.8B $1.9B $2B $1.8B $1.5B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$220M $230.7M $68.5M -$111M -$50.7M
Change in Inventories -$645.6M $373.2M -$377.2M -$681.7M $359M
Cash From Operations $1.9B $2.7B $1.7B $3.7B $5.3B
 
Capital Expenditures $2B $1.8B $1.7B $1.4B $2.1B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$237.8M -$2.6B -$1.6B -$2.5B -$4.9B
 
Dividends Paid (Ex Special Dividend) -$1B -$405.1M -$382.4M -$374.7M -$451.8M
Special Dividend Paid
Long-Term Debt Issued $1.3B $995.2M $231.6M $222.2M $987.5M
Long-Term Debt Repaid -$91.9M -$70M -$222.6M -$378.8M -$383.9M
Repurchase of Common Stock -- -- -- -$29.6K -$277.2M
Other Financing Activities -$2M -$1.9M -$472.1K -$7.4K -$37.7M
Cash From Financing -$145.5M $131.7M -$877.4M -$905.8M -$460.6M
 
Beginning Cash (CF) $6.5B $8.1B $8.1B $6.5B $6.8B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.6B $294M -$735.5M $330.6M -$17.3M
Ending Cash (CF) $7.9B $8.6B $7.9B $7.3B $7.3B
 
Levered Free Cash Flow -$36.2M $913.6M $83.8M $2.3B $3.2B
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders $501.5M $63M $150.2M $535.6M $871.7M
Depreciation & Amoritzation $457.3M $490.9M $516.5M $524.4M $422.1M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$145.4M $15.7M -$41.7M -$46M -$86.8M
Change in Inventories -$377.7M $387.5M $5.6K -$147.4M $377.9M
Cash From Operations $745.1M $1B $986.8M $1.4B $2.2B
 
Capital Expenditures $477.1M $528.5M $451.3M $451.6M $617.8M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$254.1M -$463.6M -$484.4M -$1.1B -$2B
 
Dividends Paid (Ex Special Dividend) -$1.6M $5.4M -$5.6M -$16.5M -$11M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $621.4M -$14.9M $2.9M $200.9M $499.9M
Long-Term Debt Repaid -$50M -$2M -$91.8M -$308.2M -$171.9M
Repurchase of Common Stock -- -- -- -$29.6K -$6.3M
Other Financing Activities -$10.2K -$19.4K -$32.3K $21K -$855.2K
Cash From Financing $508.2M -$106.4M -$221.4M -$237.4M $214.5M
 
Beginning Cash (CF) $7B $7.9B $7.2B $6.8B $6.6B
Foreign Exchange Rate Adjustment -$49.7M $353M $319M $49.3M $221.9M
Additions / Reductions $999.2M $430.8M $280.9M $120.1M $325.3M
Ending Cash (CF) $7.9B $8.6B $7.9B $7.3B $7.3B
 
Levered Free Cash Flow $268M $472.2M $535.4M $969M $1.5B
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders $997.9M $1.5B $936.3M $2.6B --
Depreciation & Amoritzation $1.8B $2B $1.9B $1.8B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$122.1M $121.7M $116.8M -$196.4M --
Change in Inventories -$621.7M -$330.9M -$50M -$433.3M --
Cash From Operations -$49.6M $3.7B $2.6B $3.7B $4.6B
 
Capital Expenditures $2B $1.9B $1.5B $1.4B $1.7B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$322.1M -$2.7B -$1.5B -$3.1B --
 
Dividends Paid (Ex Special Dividend) -$720.7M -$402.2M -$353.1M -$421.2M -$243.8M
Special Dividend Paid
Long-Term Debt Issued $1.8B $583.8M -- -- --
Long-Term Debt Repaid -$81.4M -$192.4M -$117.2M -$375.5M --
Repurchase of Common Stock -- -- -- -$153.5M --
Other Financing Activities -$1.8M -$1.8M -- -$38.8M --
Cash From Financing $2.1B -$1.9B -$836.4M -$1.1B --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.7B -$947.6M $199.4M -$546.9M --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$2B $1.7B $1.1B $2.3B --
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $1.1B $952.9M $2.1B $3.7B --
Depreciation & Amoritzation $1.9B $2B $1.8B $1.5B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $230.7M $68.5M -$111M -$50.7M --
Change in Inventories $373.2M -$377.2M -$681.7M $359M --
Cash From Operations $2.7B $1.7B $3.7B $5.3B --
 
Capital Expenditures $1.8B $1.7B $1.4B $2.1B --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.6B -$1.6B -$2.5B -$4.9B --
 
Dividends Paid (Ex Special Dividend) -$405.1M -$382.4M -$374.7M -$451.8M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $995.2M $231.6M $222.2M $987.5M --
Long-Term Debt Repaid -$70M -$222.6M -$378.8M -$383.9M --
Repurchase of Common Stock -- -- -$29.6K -$277.2M --
Other Financing Activities -$1.9M -$472.1K -$7.4K -$37.7M --
Cash From Financing $131.7M -$877.4M -$905.8M -$460.6M --
 
Beginning Cash (CF) $32.8B $30.8B $28.8B $26.9B --
Foreign Exchange Rate Adjustment $162.2M $519.5M $383.7M $491.8M --
Additions / Reductions $294M -$735.5M $330.6M -$17.3M --
Ending Cash (CF) $33.4B $30.4B $29.3B $27B --
 
Levered Free Cash Flow $913.6M $83.8M $2.3B $3.2B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock